Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Journal of Psychiatry & Neuroscience : JPN|February 12, 2002
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's diseaseMichel Cyr, Frederic Calon, Marc Morissette, et al.
Molecular and Cellular Endocrinology|June 3, 2008
Estrogen and SERM neuroprotection in animal models of Parkinson's diseaseMarc Morissette, Sara Al Sweidi, Sophie Callier, et al.
Canadian Journal of Physiology and Pharmacology|January 7, 2010
Neuregulin beta1 enhances peak glutamate-induced intracellular calcium levels through endoplasmic reticulum calcium release in cultured hippocampal neuronsJason Schapansky, Marc Morissette, Gary Odero, et al.
CNS Neuroscience & Therapeutics|June 19, 2010
Steroids-dopamine interactions in the pathophysiology and treatment of CNS disordersMaria Gabriela Sánchez, Mélanie Bourque, Marc Morissette, et al.
Synapse (New York, N.Y.)|November 8, 2002
Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in miceMyreille D'Astous, Marc Morissette, Bastien Tanguay, et al.
Neurobiology of Aging|July 4, 2012
Implication of GPER1 in neuroprotection in a mouse model of Parkinson's diseaseMélanie Bourque, Marc Morissette, Mélissa Côté, et al.
Biochemical Pharmacology|August 20, 2013
Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesiaGolnasim Riahi, Marc Morissette, Pershia Samadi, et al.
Pageof 8